Safety and immunogenicity of investigational Shigella conjugate vaccines in Israeli volunteers.

Benzer Materyaller

• Safety and Immunogenicity of Improved Shigella O-Specific Polysaccharide-Protein Conjugate Vaccines in Adults in Israel
  Yazar:: Passwell, Justen H., ve diğerleri
  Baskı/Yayın Bilgisi: (2001)
• Synthesis, characterization, and clinical evaluation of conjugate vaccines composed of the O-specific polysaccharides of Shigella dysenteriae type 1, Shigella flexneri type 2a, and Shigella sonnei (Plesiomonas shigelloides) bound to bacterial toxoids.
  Yazar:: Taylor, D N, ve diğerleri
  Baskı/Yayın Bilgisi: (1993)
• Preparation, characterization, and immunogenicity of conjugates composed of the O-specific polysaccharide of Shigella dysenteriae type 1 (Shiga's bacillus) bound to tetanus toxoid.
  Yazar:: Chu, C Y, ve diğerleri
  Baskı/Yayın Bilgisi: (1991)
• Detection of antibodies to Shigella lipopolysaccharide in urine after natural Shigella infection or vaccination.
  Yazar:: Cohen, D, ve diğerleri
  Baskı/Yayın Bilgisi: (1996)
• Synthesis, characterization, and immunogenicity in mice of Shigella sonnei O-specific oligosaccharide-core-protein conjugates
  Yazar:: Robbins, John B., ve diğerleri
  Baskı/Yayın Bilgisi: (2009)